4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing TreatmentDigestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisActive, not recruitingNot stated2026-10-01NCT06447168
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness TearsRotator Cuff Injuries, Rupture, Shoulder Injuries, Tendon Injuries, injuryRecruitingNot applicable2026-09-28NCT05444465
Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?cardiovascular disorder, heart disorder, heart failureNot yet recruitingPhase 42026-03-30NCT07295522
XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) PatientsLocally Advanced Rectal Cancer (LARC)Not yet recruitingPhase 22026-02-02NCT07381777